Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
40%
Ph phase_2
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(1)
Other(4)

Detailed Status

unknown4
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

completed120%
unknown480%

Recent Activity

0 active trials
Showing 5 of 5
unknownphase_2

Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL

NCT03736616
unknown

EBMT ADWP Prospective Non-interventional Study: Post-AHSCT Management in SSC Patients (NISSC-2)

NCT03444805
completed

EBMT ADWP Prospective Non Interventional Study : AutoHSCT in SSc Patients

NCT02516124
unknownnot_applicable

De-escalated Treatment Approach for Adult Ph-negative Acute Lymphoblastic Leukemia (ALL)

NCT03462095
unknownnot_applicable

Multicenter Clinical Trial for Adult Ph-negative ALL. Non-intensive But Non-iterruptive Treatment

NCT01193933

Clinical Trials (5)

Showing 5 of 5 trials
NCT03736616Phase 2

Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL

Unknown
NCT03444805

EBMT ADWP Prospective Non-interventional Study: Post-AHSCT Management in SSC Patients (NISSC-2)

Unknown
NCT02516124

EBMT ADWP Prospective Non Interventional Study : AutoHSCT in SSc Patients

Completed
NCT03462095Not Applicable

De-escalated Treatment Approach for Adult Ph-negative Acute Lymphoblastic Leukemia (ALL)

Unknown
NCT01193933Not Applicable

Multicenter Clinical Trial for Adult Ph-negative ALL. Non-intensive But Non-iterruptive Treatment

Unknown

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5